<%@LANGUAGE="JAVASCRIPT" CODEPAGE="65001"%> Welcome to the Sullivan Group!

Welcome

People

Research Program

Publications

Resources

Group Highlights:

Mar 2013:
Elizabeth Kelley was selected to participate in the 63rd Lindau Nobel Laureate Meeting.

Feb 2013:
Elizabeth Kelley publishes a review in Chemical Society Reviews titled "Stimuli-Responsive Copolymer Solution and Surface Assemblies for Biomedical Applications."

Sept 2012:
John Larsen publishes a manuscript in the Journal of Gene Medicine titled "Requirements for the Nuclear Entry of Polyplexes and Nanoparticles During Mitosis."

Mar 2012:
Meghan Reilly publishes a manuscript in Molecular Pharmaceutics titled "Polyplexes Traffic Through Caveolae to the Golgi and Endoplasmic Reticulum en Route to the Nucleus."

Jan 2012:
Meghan Reilly publishes a manuscript in Molecular Pharmaceutics titled "Histone H3 Tail Peptides and Poly(ethylenimine) have Synergistic Effects for Gene Delivery."

Nov 2011:
Elizabeth Kelley selected to present in the ACS Excellence in Graduate Student Research Symposium

July 2011:
Elizabeth Kelley receives award at Polymers Gordon Research Conference

May 2011:
Dr. Sullivan awarded the 2011 College of Engineering Outstanding Junior Faculty Award

Oct 2010:
Tejal Naik receives second place award in the 2010 UMBC undergraduate research symposium

Oct 2010:
Dr. Sullivan writes chapter on "Self-Unpackaging Gene Delivery Scaffolds" in Organelle-Specific Pharmaceutical Nanotechnology

Apr 2010:
Elizabeth Kelley receives NDSEG Graduate Fellowship

Apr 2010:
Peter Millili graduates with doctoral degree

Mar 2010:
Abbygail Palmer receives NOBCChE P&G Fellowship

Oct 2009:
Tejal Naik wins 1st  prize at UD Undergraduate Research Symposium

Apr 2009:
Peter Millili wins poster competition for the Delaware Valley Chapter of the International Society of Pharmaceutical Engineers

Apr 2009:
Stephanie Myrick gets honorable mention in the Student Research Poster Competition at the 2009 ASBMB Conference

Apr 2009:
Peter Millili is awarded the Department of Chemical Engineering Teaching Fellowship


Millicent O. Sullivan
Assistant Professor
Chemical Engineering
University of Delaware
Phone: 302-831-8072
Fax: 302-831-1048
Email: msulliva@udel.edu
Full CV
Honors and Awards:
UD COE Outstanding Junior Faculty Award, 2011
NSF CAREER Award, 2008
UDRF Research Award, 2007
 
 

 

Welcome to the Sullivan Group!

Designing biomaterials that can effectively deliver macromolecular therapeutics presents a persistent challenge. In particular, such materials must be structured to accomplish efficient, highly specific site targeting, both at the cellular and at the sub-cellular level. They must also be responsive to cellular and environmental cues at their target site in order to initiate the appropriate levels and timing of therapeutic release.

The Sullivan laboratory is focused on the design of drug delivery biomaterials that can accomplish cell and organelle-specific delivery of macromolecular therapeutics by tuned biodegradation. We are particularly interested in understanding how such macromolecular therapeutics might be used to modulate or improve the structure of newly synthesized extracellular matrix (ECM). As such, we are focused on quantitatively understanding the principles that govern fibrosis and ECM regeneration, and on designing materials that can target and respond to cellular cues during these processes.


Research:

Histone mimetic delivery systems
Biomimetic materials capable of regulating DNA accessibility provide a novel approach to DNA delivery. The histone H3 tail, trimethylated at lysine 4 by nucleosome remodeling factors, has been implicated in mechanisms for chromatin activation. Our research examines H3 tail peptides both with and without a trimethylated K4 for their potential as gene delivery materials ... Read more>>
ECM fragment-targeted delivery vehicles
Collagens have been employed extensively for tissue regeneration and wound healing applications owing to their compatibility and bioactivity. However, natural collagen remodeling processes have not been exploited to improve therapeutic efficacy of factors immobilized in collagen scaffolds, despite the potential utility of such strategies in targeted delivery.  We will employ collagen-mimetic peptides (CMPs) in concert with DNA-binding peptides/polymers (DBPs) to engineer polyplex-modified collagen scaffolds capable of efficient gene delivery to cells involved in tissue repair... Read more>>
Surface-mediated delivery systems
Incorporation of DNA onto biomaterial scaffolds may avoid the limitations associated with bolus delivery of cationic polymer-complexed DNA. These scaffolds have the potential to increase cell transfection by maintaining a high concentration of DNA in the cellular microenvironment. Surface immobilization of DNA also allows spatial targeting of cells ... Read more>>
Nucleic acid nanoconjugates
The development of targeted, efficient, and safe methods for RNA delivery is widely considered the limiting factor towards its effective therapeutic implementation. A major challenge to in vivo RNA delivery has been the development of materials that can overcome intra- and extra- cellular barriers while remaining simple from the standpoint of formulation and clinical administration.  Our specific goal is to create siRNA delivery conjugates containing protective and targeting features as well as components that enable their “bedside” formulation ... Read more>>
Peptide-functionalized polymer assemblies
Bio-responsive, polymeric nanocontainers may be useful for addressing concerns with inefficient drug delivery, transport across biological barriers and non-ideal serum-stability associated with many drug delivery methods. We are investigating the effects of solution conditions on block copolymer self-assembly, providing a variety of hybrid nanostructures ideally suited for the development of biomedical delivery agents ... Read more>>